Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men

Journal of Nutritional Biochemistry

Volumn 21, Issue 10, 2010, Pages 983-990

  Dekker, Mark J ^a   Graham, Terry E ^a   Ooi, T C ^b   Robinson, Lindsay E ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Adipose tissue biopsy; Exercise; Incretins; Inflammation; Oral fat tolerance test; Postprandial; VLDL

Indexed keywords

CHYLOMICRON; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INTERLEUKIN 6; MESSENGER RNA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EXERCISE; FAT INTAKE; FAT TOLERANCE TEST; HEART RATE; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; MALE; POSTPRANDIAL STATE; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; AGED; DIETARY FATS; EXERCISE; FASTING; HUMANS; HYPERTRIGLYCERIDEMIA; INTERLEUKIN-6; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; RECEPTORS, GASTROINTESTINAL HORMONE; RNA, MESSENGER;

EID: 77956652380     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.08.004     Document Type: Article

References (52)

1. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298(3):309-316.
2. Nordestgaard B.G., Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298(3):299-308.
3. Kolovou G.D., Anagnostopoulou K.K., Pavlidis A.N., Salpea K.D., Iraklianou S.A., Tsarpalis K., et al. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis 2005, 4:21.
4. Dekker M.J., Wright A.J., Mazurak V.C., Marangoni A.G., Rush J.W., Graham T.E., et al. Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests. J Nutr Biochem 2009, 20(9):694-704.
5. Herd S.L., Lawrence J.E., Malkova D., Murphy M.H., Mastana S., Hardman A.E. Postprandial lipemia in young men and women of contrasting training status. J Appl Physiol 2000, 89(5):2049-2056.
6. Malkova D., Hardman A.E., Bowness R.J., Macdonald I.A. The reduction in postprandial lipemia after exercise is independent of the relative contributions of fat and carbohydrate to energy metabolism during exercise. Metabolism 1999, 48(2):245-251.
7. Gill J.M., Frayn K.N., Wootton S.A., Miller G.J., Hardman A.E. Effects of prior moderate exercise on exogenous and endogenous lipid metabolism and plasma factor VII activity. Clin Sci (Lond) 2001, 100(5):517-527.
8. Gill J.M., Al Mamari A., Ferrell W.R., Cleland S.J., Sattar N., Packard C.J., et al. Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis 2006, 185(1):87-96.
9. Murphy M.H., Nevill A.M., Hardman A.E. Different patterns of brisk walking are equally effective in decreasing postprandial lipaemia. Int J Obes Relat Metab Disord 2000, 24(10):1303-1309.
10. Gill J.M., Al Mamari A., Ferrell W.R., Cleland S.J., Packard C.J., Sattar N., et al. Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol 2004, 44(12):2375-2382.
11. Malkova D., Evans R.D., Frayn K.N., Humphreys S.M., Jones P.R., Hardman A.E. Prior exercise and postprandial substrate extraction across the human leg. Am J Physiol Endocrinol Metab 2000, 279(5):E1020-E1028.
12. Zhang J.Q., Ji L.L., Fretwell V.S., Nunez G. Effect of exercise on postprandial lipemia in men with hypertriglyceridemia. Eur J Appl Physiol 2006, 98(6):575-582.
13. Timlin M.T., Barrows B.R., Parks E.J. Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men. Diabetes 2005, 54(9):2694-2701.
14. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997, 82(12):4196-4200.
15. Febbraio M.A., Steensberg A., Starkie R.L., McConell G.K., Kingwell B.A. Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise. Metabolism 2003, 52(7):939-944.
16. van Hall G., Steensberg A., Sacchetti M., Fischer C., Keller C., Schjerling P., et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 2003, 88(7):3005-3010.
17. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101(15):1767-1772.
18. Yudkin J.S., Juhan-Vague I., Hawe E., Humphries S.E., di Minno G., Margaglione M., et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004, 53(7):852-857.
19. Nonogaki K., Fuller G.M., Fuentes N.L., Moser A.H., Staprans I., Grunfeld C., et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 1995, 136(5):2143-2149.
20. Gama R., Norris F., Morgan L., Hampton S., Wright J., Marks V. Elevated post-prandial gastric inhibitory polypeptide concentrations in hypertriglyceridaemic subjects. Clin Sci (Lond) 1997, 93(4):343-347.
21. Wasada T., McCorkle K., Harris V., Kawai K., Howard B., Unger R.H. Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs. J Clin Invest 1981, 68(4):1106-1107.
22. Thomsen C., Rasmussen O., Lousen T., Holst J.J., Fenselau S., Schrezenmeir J., et al. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 1999, 69(6):1135-1143.
23. Thomsen C., Storm H., Holst J.J., Hermansen K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr 2003, 77(3):605-611.
24. Meier J.J., Gethmann A., Gotze O., Gallwitz B., Holst J.J., Schmidt W.E., et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 2006, 49(3):452-458.
25. Rudovich N., Kaiser S., Engeli S., Osterhoff M., Gogebakan O., Bluher M., et al. GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regul Pept 2007, 142(3):138-145.
26. O'Connor A.M., Pola S., Ward B.M., Fillmore D., Buchanan K.D., Kirwan J.P. The gastroenteroinsular response to glucose ingestion during postexercise recovery. Am J Physiol Endocrinol Metab 2006, 290(6):E1155-E1161.
27. Dekker M.J., Wright A.J., Mazurak V.C., Graham T.E., Marangoni A.G., Robinson L.E. New oral fat tolerance tests feature tailoring of the polyunsaturated/saturated fatty acid ratio to elicit a specific postprandial response. Appl Physiol Nutr Metab 2007, 32(6):1073-1081.
28. Canadian Diabetes Association Clinical practice guidelines 2003 http://www.diabetes.ca/cpg2003/faq.aspx.
29. Balady G., Berra K., Golding L., Gordon N., Mahler D., Myers J., et al. ACSM's guidelines for exercise testing and prescription 2000, Lippincott Williams and Wilkins, New York (NY). 6th ed.
30. Gusba J.E., Wilson R.J., Robinson D.L., Graham T.E. Interleukin-6 and its mRNA responses in exercise and recovery: relationship to muscle glycogen. Scand J Med Sci Sports 2008, 18(1):77-85.
31. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
32. Stalenhoef A.F., de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008, 19(4):355-361.
33. Zhang J.Q., Ji L.L., Fogt D.L., Fretwell V.S. Effect of exercise duration on postprandial hypertriglyceridemia in men with metabolic syndrome. J Appl Physiol 2007, 103(4):1339-1345.
34. Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 2004, 12(3):454-460.
35. Gill J.M., Mees G.P., Frayn K.N., Hardman A.E. Moderate exercise, postprandial lipaemia and triacylglycerol clearance. Eur J Clin Invest 2001, 31(3):201-207.
36. Tsetsonis N.V., Hardman A.E. Effects of low and moderate intensity treadmill walking on postprandial lipaemia in healthy young adults. Eur J Appl Physiol Occup Physiol 1996, 73(5):419-426.
37. Herd S.L., Kiens B., Boobis L.H., Hardman A.E. Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity. Metabolism 2001, 50(7):756-762.
38. Gill J.M., Hardman A.E. Postprandial lipemia: effects of exercise and restriction of energy intake compared. Am J Clin Nutr 2000, 71(2):465-471.
39. Bjorkegren J., Packard C.J., Hamsten A., Bedford D., Caslake M., Foster L., et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996, 37(1):76-86.
40. James A.P., Slivkoff-Clark K., Mamo J.C. Prior exercise does not affect chylomicron particle number following a mixed meal of moderate fat content. Lipids Health Dis 2007, 6:8.
41. Harrison M., O'Gorman D.J., McCaffrey N., Hamilton M.T., Zderic T.W., Carson B.P., et al. Influence of acute exercise with and without carbohydrate replacement on postprandial lipid metabolism. J Appl Physiol 2009, 106(3):943-949.
42. Burton F.L., Malkova D., Caslake M.J., Gill J.M. Energy replacement attenuates the effects of prior moderate exercise on postprandial metabolism in overweight/obese men. Int J Obes (Lond) 2008, 32(3):481-489.
43. Sniderman A.D., Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb 1993, 13(5):629-636.
44. Keller C., Keller P., Marshal S., Pedersen B.K. IL-6 gene expression in human adipose tissue in response to exercise - effect of carbohydrate ingestion. J Physiol 2003, 550(Pt 3):927-931.
45. Dekker M.J., Lee S., Hudson R., Kilpatrick K., Graham T.E., Ross R., et al. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism 2007, 56(3):332-338.
46. Bruun J.M., Helge J.W., Richelsen B., Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006, 290(5):E961-E967.
47. Salas-Salvado J., Bullo M., Garcia-Lorda P., Figueredo R., Del Castillo D., Bonada A., et al. Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. Int J Obes (Lond) 2006, 30(12):1714-1720.
48. Kim S.J., Nian C., McIntosh C.H. Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem 2007, 282(12):8557-8567.
49. Gault V.A., McClean P.L., Cassidy R.S., Irwin N., Flatt P.R. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia 2007, 50(8):1752-1762.
50. McClean P.L., Irwin N., Cassidy R.S., Holst J.J., Gault V.A., Flatt P.R. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab 2007, 293(6):E1746-E1755.
51. Miyawaki K., Yamada Y., Ban N., Ihara Y., Tsukiyama K., Zhou H., et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002, 8(7):738-742.
52. Weaver R.E., Donnelly D., Wabitsch M., Grant P.J., Balmforth A.J. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model. Int J Obes (Lond) 2008, 32(11):1705-1711.